Tse, G. ., Ariti, C. ., Bafadhel, M. ., Papi, A. ., Carter, V. ., Zhou, J. ., … Price, D. . (2024). Oral Corticosteroid-Related Healthcare Resource Utilization and Associated Costs in Patients with COPD. Adv Ther. http://doi.org/10.1007/s12325-024-03024-3
corticosteroids
Bloom, C. I., Yang, F. ., Hubbard, R. ., Majeed, A. ., & Wedzicha, J. A. (2024). Association of Dose of Inhaled Corticosteroids and Frequency of Adverse Events. Am J Respir Crit Care Med. http://doi.org/10.1164/rccm.202402-0368OC
Cardwell, C. R., McDowell, R. D., Hughes, C. M., Busby, J. ., & Murchie, P. . (2024). Oral prednisolone and warfarin and risk of oesophageal cancer: A case-control study. Cancer Epidemiol, 90, 102552. http://doi.org/10.1016/j.canep.2024.102552
Tse, G. ., Emmanuel, B. ., Ariti, C. ., Bafadhel, M. ., Papi, A. ., Carter, V. ., … Price, D. . (2023). A Long-Term Study of Adverse Outcomes Associated With Oral Corticosteroid Use in COPD. Int J Chron Obstruct Pulmon Dis, 18, 2565–2580. http://doi.org/10.2147/copd.s433326